Steri-7 Xtra High Level Surface Disinfectant Wipes (80)
This is what Steri-7 say about their products:
At it’s most fundamental, biosecurity is everyday common-sense; basic hygiene, washing your hands as often as possible, all the things we do, or should do, as a matter of course. But wherever we go, we’ll come in contact with micro organisms and pathogens. Some are simply unpleasant; many are deadly. Biosecurity needed a champion.
That’s why we developed a revolutionary system called Reactive Barrier Technology. Reactive Barrier Technology is a specialised micro emulsion which provides an optional sustained release system and offers powerful and sustained protection between cleans.
Like all our biosecurity protocols, processes and management systems, Reactive Barrier Technology is designed to offer the best possible protection against the harmful micro organisms that surround us everyday.
It’s an important part of one of our simplest and most effective protocols: BREAK–TREAT–PREVENT.
As the World Health Organisation says, just washing your hands regularly can help BREAK the chain of infection we’re exposed to in our daily lives. But we go further.
We have developed a range of biocidal disinfectant cleaners that TREAT and destroy the pathogens at source. And Reactive Barrier Technology helps PREVENT any further re-infection.
Break-Treat-Prevent is just one of the many Biosecurity solutions we have in the locker. Our R&D team is constantly developing new ideas and innovative products.
At STERI-7, our passion is not just BioSecurity, it’s LifeSecurity.
7th GENERATION LIQUID MICRO EMULSION POLYMERIC MATRIX DISINFECTANT CLEANER IN A WIPE.
REACTIVE BARRIER TECHNOLOGY
ONE STAGE PROCESS
EASE OF USE
MULTI SURFACE TREATMENT
PERFECT BALANCE BETWEEN SAFETY AND EFFICACY
TESTED AND PROVEN IN
THE REAL WORLD
RAPID KILL RATE up to 99.9999% IN SECONDS
A SELECTION OF PATHOGENS STERI-7 XTRA KILLS:
Salmonella cholerae suis
Mycobacterium Terrae (TB)
Influenza A H1N1 (Swine Flu)
The recent Coronavirus (2019-nCoV) has been found to be at least 70% similar in genetic sequence to MERS and SARS